Marksans Pharma Q2FY17

1. Net Profit At Rs 0.4 cr v/s Rs 35.7 cr (YoY) 
2. Total Income down 26.8% At Rs 187.1 cr v/s Rs 255.5 cr (YoY) 
3. EBITDA down 87.5% At Rs 6.4 cr v/s Rs 51.4 cr (YoY) 
4. EBITDA Margin At 3.45 v/s 20.1% (YoY)